Mark Cooper, PhD

Mark Cooper received his PhD in cellular biophysics from the University of California at Berkeley (1985).   He then studied electrical stimulation as a NASA Postdoctoral Associate and brain astrocyte physiology as a Postdoctoral Associate with the Howard Hughes Medical Institute. 

During his career, Dr Cooper has studied the interface between electrophysiology, cell behaviours, tissue injury/repair, and neuroinflammation. 

As an Associate Professor Emeritus at the University of Washington, Dr Cooper has worked closely with clinicians to develop applications of Low-Dose Naltrexone (LDN), as well as Vitamin D Receptor activators (VDR-agonists), to treat a variety of chronic inflammatory disorders, including Complex Regional Pain Syndrome, Infectious Keratitis, and Long-Covid.

Topic
Vitamin D Resistance in Chronic Illnesses: Etiologies, Pathologies, and Treatments